| The following articles are from the past month only. Click here for older news. |
| |
|
First
Previous
Next
|
|
12/09/22 08:44
|
Astrazeneca PLC
(AZN)
|
AstraZeneca shares further Imfinzi, Tagrisso, Enhertu trial data
|
ALN
|
|
09/09/22 14:31
|
Astrazeneca PLC
(AZN)
|
AstraZeneca, Merck's Lynparza shows survival benefit in ovarian cancer
|
ALN
|
|
05/09/22 08:51
|
Astrazeneca PLC
(AZN)
|
AstraZeneca gets approval for two treatments in US and China
|
ALN
|
|
30/08/22 14:10
|
Astrazeneca PLC
(AZN)
|
AstraZeneca says Evusheld Covid-19 treatment approved in Japan
|
ALN
|
|
29/08/22 19:16
|
Astrazeneca PLC
(AZN)
|
AstraZeneca says data shows Farxiga reduces cardiovascular death risk
|
ALN
|
|
26/08/22 06:03
|
Astrazeneca PLC
(AZN)
|
CORRECT: Japan approves Astra's Lynparza, Tagrisso, and Ultomiris
|
ALN
|
|
25/08/22 08:57
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: Japan approves Astra's Lynparza, Tagrisso, and Ultomiris
|
ALN
|
|
24/08/22 08:00
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca to present cancer drug data at oncology congress
|
ALN
|
|
16/08/22 08:36
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca's Lynparza wins FDA priority review in US
|
ALN
|
|
15/08/22 08:42
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca's Enhertu meets endpoints in breast cancer trial
|
ALN
|
|
12/08/22 08:13
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca's Enhertu approved for more patients in US
|
ALN
|
|
09/08/22 13:27
|
Astrazeneca PLC
(AZN)
|
AstraZeneca reports promising results for antibody drug conjugate
|
ALN
|
|
08/08/22 08:59
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca's Enhertu approved for more patients in US
|
ALN
|
|
05/08/22 13:38
|
Astrazeneca PLC
(AZN)
|
IN BRIEF: AstraZeneca's Calquence tablet formulation approved in US
|
ALN
|
|
04/08/22 09:41
|
Astrazeneca PLC
(AZN)
|
AstraZeneca, Merck's Lynparza approved in EU for breast cancer
|
ALN
|
|
29/07/22 09:11
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca lifts sales guidance; promotes Demare to chair
|
ALN
|
|
25/07/22 09:32
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca wins two recommendations, one priority review
|
ALN
|
|
19/07/22 09:22
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca breast cancer drug wins approval in EU
|
ALN
|
|
30/06/22 10:17
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca sees positive data for lung cancer drug Imfinzi
|
ALN
|
|
27/06/22 09:04
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca wins EU recommendation for breast cancer drugs
|
ALN
|
|
23/06/22 15:59
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Wilson disease treatment shows promise in phase 3 trials
|
ALN
|
|
21/06/22 22:01
|
Astrazeneca PLC
(AZN)
|
Merck & Co, Astra drug improves survival in prostate cancer sufferers
|
ALN
|
|
21/06/22 08:32
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's polyneuropathy candidate Eplontersen sees positive data
|
ALN
|
|
13/06/22 13:52
|
Astrazeneca PLC
(AZN)
|
Daiichi Sankyo doses first person in breast cancer treatment trial
|
ALN
|
|
09/06/22 10:34
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Calquence shows longer survival rate for leukaemia form
|
ALN
|
|
08/06/22 09:48
|
Astrazeneca PLC
(AZN)
|
AstraZeneca antibody reduces risk of severe Covid-19 or death
|
ALN
|
|
06/06/22 09:57
|
Astrazeneca PLC
(AZN)
|
AstraZeneca sees breast cancer drug Enhertu improve median overall survival
|
ALN
|
|
23/05/22 08:58
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca Covid vaccine wins booster jab approval in EU
|
ALN
|
|
17/05/22 09:12
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca wins license to make and sell Covid antibodies
|
ALN
|
|
16/05/22 14:34
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's PTO27 shows positive results in people with asthma
|
ALN
|
|
16/05/22 12:16
|
Astrazeneca PLC
(AZN)
|
NetScientific shares jump after ‘impressive’ results of Covid-19 test
|
ALN
|
|
05/05/22 09:39
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Enhertu approved in US, results for Farxiga, Ultomiris
|
ALN
|
|
04/05/22 09:19
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Imfinzi granted US priority review for bile duct cancer
|
ALN
|
|
29/04/22 10:18
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca backs yearly outlook but quarterly profit down
|
ALN
|
|
28/04/22 09:51
|
Astrazeneca PLC
(AZN)
|
AstraZeneca wins US approval for generalised myasthenia gravis drug
|
ALN
|
|
27/04/22 09:44
|
Astrazeneca PLC
(AZN)
|
AstraZeneca, Daiichi Sankyo cancer drug secures US regulatory boost
|
ALN
|
|
25/04/22 08:32
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Tremelimumab-Imfinzi combo to get US priority review
|
ALN
|
|
21/04/22 06:01
|
Astrazeneca PLC
(AZN)
|
AstraZeneca says no severe virus cases or deaths after taking antibody
|
ALN
|
|
19/04/22 08:17
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Enhertu wins priority review by FDA for lung cancer
|
ALN
|
|
06/04/22 20:57
|
Astrazeneca PLC
(AZN)
|
AstraZeneca notes positive follow-up results for Ultomiris
|
ALN
|
|
05/04/22 07:00
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's AZD8233 shows positive results for hypercholesterolemia
|
ALN
|
|
29/03/22 08:48
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Ondexxya approved in Japan to treat major bleeds
|
ALN
|
|
28/03/22 08:21
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: AstraZeneca's Evusheld backed in EU for Covid-19 prevention
|
ALN
|
|
24/03/22 20:28
|
Astrazeneca PLC
(AZN)
|
UPDATE: EU drug watchdog approves AstraZeneca Covid prevention jab
|
ALN
|
|
24/03/22 16:56
|
Astrazeneca PLC
(AZN)
|
TOP NEWS: EU drug watchdog approves AstraZeneca Covid prevention jab
|
ALN
|
|
24/03/22 09:05
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Imfinzi fails to meet endpoint in Phase 3 trial
|
ALN
|
|
17/03/22 09:01
|
Astrazeneca PLC
(AZN)
|
AstraZeneca's Alexion to pay $775 million in Ultomiris settlement
|
ALN
|
|
16/03/22 18:21
|
Astrazeneca PLC
(AZN)
|
AstraZeneca, Merck & Co's Lynparza improves cancer survival rate
|
ALN
|
|
11/03/22 21:40
|
Astrazeneca PLC
(AZN)
|
IN BRIEF: AstraZeneca's Lynparza approved in US as adjuvant treatment
|
ALN
|
|
01/03/22 09:39
|
Astrazeneca PLC
(AZN)
|
Astra closes $760 million human monoclonal antibody collaboration
|
ALN
|
